Form 483

High Chemical Company, Div of National Generic Distributors Form 483, 2019-02-08

FDA issued a Form 483 to High Chemical Company, Div of National Generic Distributors on 2019-02-08 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

High Chemical Company, Div of National Generic Distributors · Levittown, United States · Issued February 8, 2019

Overview

  • 6 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Feb 2019
21 CFR 211.100(a)

Absence of Written Procedures

Cited by David A Oluwo

8 Feb 2019
21 CFR 211.166(a)

Lack of written stability program

Cited by David A Oluwo

8 Feb 2019
21 CFR 211.198(a)

Quality Control Review

Cited by David A Oluwo

8 Feb 2019
21 CFR 211.84(d)(2)

Reports of Analysis (Components)

Cited by David A Oluwo

8 Feb 2019
21 CFR 211.67(b)

Written procedures fail to include

Cited by David A Oluwo

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere